Literature DB >> 20663563

Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: analysis of the retinal nerve fiber layer map for glaucoma detection.

Christopher K S Leung1, Shi Lam, Robert N Weinreb, Shu Liu, Cong Ye, Lan Liu, Jing He, Gilda W K Lai, Taiping Li, Dennis S C Lam.   

Abstract

OBJECTIVE: To evaluate the diagnostic performance of the retinal nerve fiber layer (RNFL) thickness deviation map imaged by a spectral-domain optical coherence tomography (OCT; Cirrus HD-OCT, Carl Zeiss Meditec Inc, Dublin, CA) and compare its sensitivity and specificity for glaucoma detection with circumpapillary RNFL measurement derived from the standard 3.46 mm diameter circle scan.
DESIGN: Prospective, cross-sectional study. PARTICIPANTS: We included 102 normal subjects and 121 glaucoma patients.
METHODS: One eye from each individual was imaged with Cirrus HD-OCT and Stratus OCT (Carl Zeiss Meditec Inc.). Glaucoma was defined based on the presence of visual field defects with the Humphrey visual field analyzer (Carl Zeiss Meditec Inc.). A scoring system (0-5) was developed to analyze the RNFL thickness deviation map taking the defect size, shape, depth, location, and distance from the disc margin into consideration. Each of these features was scored independently by a masked observer with a highest total score of 5 (glaucomatous RNFL defect) and a lowest score of 0 (no RNFL defect). Sensitivity and specificity were computed with a score of > or =3, > or =4, or =5. The diagnostic performance of circumpapillary RNFL measurement was analyzed with clock-hour and average RNFL thickness categorical classification. MAIN OUTCOME MEASURES: Diagnostic sensitivity and specificity.
RESULTS: The sensitivities of the RNFL thickness deviation map ranged between 95.0% and 97.5%. There were significant differences in specificity between a map score of 5, a map score of > or =4 (87.3%), and a map score > or =3 (72.5%; P< or =0.014). A map score of 5 attained a significantly higher sensitivity (95.0%) compared with clock-hour or average RNFL thickness categorical classification by Stratus OCT or Cirrus HD-OCT (46.3%-88.4%; P< or =0.033) at a comparable level of specificity (95.1%), except when glaucoma was detected as having > or =1 clock-hour at the < or =5% level by Cirrus HD-OCT in which an equally high sensitivity (93.4%) was found but at the expense of a significantly lower specificity (83.3%; P<0.001).
CONCLUSIONS: Analysis of the RNFL thickness deviation map provides additional spatial and morphologic information of RNFL damage and significantly improves the diagnostic sensitivity for glaucoma detection compared with conventional circumpapillary RNFL measurement.
Copyright © 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20663563     DOI: 10.1016/j.ophtha.2010.01.026

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  65 in total

1.  A comparison of false positives in retinal nerve fiber layer, optic nerve head and macular ganglion cell-inner plexiform layer from two spectral-domain optical coherence tomography devices.

Authors:  Marina Leal-Fonseca; Gema Rebolleda; Noelia Oblanca; Javier Moreno-Montañes; Francisco J Muñoz-Negrete
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-12-12       Impact factor: 3.117

2.  Diagnostic ability of retinal nerve fiber layer maps to detect localized retinal nerve fiber layer defects.

Authors:  J W Shin; K B Uhm; W J Lee; Y J Kim
Journal:  Eye (Lond)       Date:  2013-06-07       Impact factor: 3.775

3.  Comparison of ability of time-domain and spectral-domain optical coherence tomography to detect diffuse retinal nerve fiber layer atrophy.

Authors:  Ko Eun Kim; Seok Hwan Kim; Jin Wook Jeoung; Ki Ho Park; Tae Woo Kim; Dong Myung Kim
Journal:  Jpn J Ophthalmol       Date:  2013-09-03       Impact factor: 2.447

4.  Combination of optic disc rim area and retinal nerve fiber layer thickness for early glaucoma detection by using spectral domain OCT.

Authors:  Min Hee Suh; Sun Kwon Kim; Ki Ho Park; Dong Myung Kim; Seok Hwan Kim; Hee Chan Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-09-25       Impact factor: 3.117

5.  Diagnostic performance and reproducibility of circumpapillary retinal nerve fiber layer thickness measurement in 10-degree sectors in early stage glaucoma.

Authors:  Hiroyo Hirasawa; Chihiro Mayama; Atsuo Tomidokoro; Makoto Araie; Aiko Iwase; Kazuhisa Sugiyama; Shoji Kishi; Naoyuki Maeda; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2014-12-19       Impact factor: 2.447

6.  Population-based evaluation of retinal nerve fiber layer, retinal ganglion cell layer, and inner plexiform layer as a diagnostic tool for glaucoma.

Authors:  Henriët Springelkamp; Kyungmoo Lee; Roger C W Wolfs; Gabriëlle H S Buitendijk; Wishal D Ramdas; Albert Hofman; Johannes R Vingerling; Caroline C W Klaver; Michael D Abràmoff; Nomdo M Jansonius
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-20       Impact factor: 4.799

7.  Optical Coherence Tomography for Ophthalmology Imaging.

Authors:  Jia Qin; Lin An
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  Parameters of ocular fundus on spectral-domain optical coherence tomography for glaucoma diagnosis.

Authors:  Yu-Lin Tao; Li-Ming Tao; Zheng-Xuan Jiang; He-Ting Liu; Kun Liang; Mo-Han Li; Xuan-Sheng Zhu; Yan-Lin Ren; Bing-Jie Cui
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

9.  A new diagnostic model of primary open angle glaucoma based on FD-OCT parameters.

Authors:  Ya-Jie Zheng; Ying-Zi Pan; Xue-Ying Li; Yuan Fang; Mei Li; Rong-Hua Qiao; Yu Cai
Journal:  Int J Ophthalmol       Date:  2018-06-18       Impact factor: 1.779

Review 10.  Optic nerve head and fibre layer imaging for diagnosing glaucoma.

Authors:  Manuele Michelessi; Ersilia Lucenteforte; Francesco Oddone; Miriam Brazzelli; Mariacristina Parravano; Sara Franchi; Sueko M Ng; Gianni Virgili
Journal:  Cochrane Database Syst Rev       Date:  2015-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.